Related Experiment Video
Updated: Aug 6, 2026
08:56
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Immunoglobulin G4-Related Sclerosing Cholangitis: A Review
Kareem Khalaf1, Natalia Causada Calo1
1Division of Gastroenterology, St. Michael's Hospital, University of Toronto, Ontario, Canada.
Clinics in Liver Disease
|July 22, 2026
Summary
Immunoglobulin G4-related sclerosing cholangitis (IgG4-SC) is a steroid-responsive condition. Treatment involves corticosteroids, with immunomodulators or rituximab for relapsing cases.
Area of Science:
- Gastroenterology and Hepatology
- Immunology
- Oncology
Background:
- Immunoglobulin G4-related sclerosing cholangitis (IgG4-SC) is a biliary manifestation of IgG4-related disease.
- It often co-occurs with type I autoimmune pancreatitis.
- IgG4-SC can be mistaken for primary sclerosing cholangitis or cholangiocarcinoma.
Purpose of the Study:
- To summarize the key aspects of IgG4-SC diagnosis and management.
- To highlight its relationship with IgG4-related disease and autoimmune pancreatitis.
- To outline current therapeutic strategies for IgG4-SC.
Main Methods:
- Diagnostic criteria integrating histology, imaging, serology, organ involvement, and treatment response were reviewed.
- Therapeutic approaches including corticosteroids, immunomodulators, and B cell-targeted therapy were analyzed.
Main Results:
- Diagnosis of IgG4-SC requires a comprehensive evaluation of multiple factors.
- Corticosteroids are the primary treatment for IgG4-SC.
- Steroid-sparing agents and rituximab are options for refractory or relapsing disease.
Conclusions:
- IgG4-SC is a distinct clinical entity within IgG4-related disease.
- Accurate diagnosis is crucial for effective management.
- A stepwise therapeutic approach is recommended for optimal patient outcomes.
Related Concept Videos
01:20Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...